Corporate Strategy


0

The Biosimilar Onslaught

January 05, 2016 / by Kevin Shi and Nawid Sayed / 0 Comment

Pharmaceutical companies face huge revenue uncertainties after the loss of patent exclusivity; but not all is lost.

The Revolution Will be Televised: Assessing Intel’s TV Strategy

July 30, 2013 / by Prashob Menon / 0 Comment

Intel is hoping to disrupt the Cable industry and generate signifcant returns in the process but will it be enough to sate investors hungry for growth?